Release Date: 20/11/13 16:13 Summary: Appendix 3B - Issue of Options Price Sensitive: No Download Document 114.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%